IQV Stock Analysis: Buy, Sell, or Hold?
IQV - IQVIA Holdings Inc.
$235.02
-2.77 (-1.16%)
▼
5d:
+12.96%
30d:
+15.66%
90d:
+48.4%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 28, 2026
0d
Smart Money Distribution
None View Scanner →
Strength: 5.1/10
Get Alerted When IQV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IQV trades at premium valuation expecting 5.1% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: IQV trades at premium valuation expecting 5.1% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$292.32
Based on 7.7% avg growth
INTRINSIC VALUE TODAY
$181.51
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IQV is currently trading at $235.02, which is considered extended relative to its 30-day fair value range of $188.06 to $223.58. From a valuation perspective, the stock is trading at a premium (Forward PE: 16.3) compared to its historical average (14.0). At these levels, the market is pricing in 5.1% annual earnings growth.
Technical Outlook: Technically, IQV is in a strong uptrend. Immediate support is located at $197.60, while resistance sits at $251.36.
Market Sentiment: IQV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $272.94 (+16.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IQV is in a strong uptrend. Immediate support is located at $197.60, while resistance sits at $251.36.
Market Sentiment: IQV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $272.94 (+16.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$188.06 -
$223.58
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
58.1%
Protect Your Profits
Holding IQV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+5.1% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($272.94)
- BULLISH: Expecting earnings turnaround to 5.1% growth with 8.7% revenue growth
Trading Range Analysis
30-Day Trading Range
$188.06 -
$223.58
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$197.60
Resistance Level
$251.36
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.29
Wall Street Target
$272.94
(+16.1%)
Revenue Growth (YoY)
8.7%
Earnings Growth (YoY)
-0.6%
Profit Margin
8.1%
Valuation Premium vs History
+5.1% premium
PE vs Historical
16.3 vs 14.0
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.1%
(market-implied from PE analysis)
1-Year Target
$247.01
(+5%)
2-Year Target
$259.60
(+11%)
3-Year Target
$272.84
(+16%)
3-Yr Target (if PE normalizes)
(PE: 16→14)
PE COMPRESSION
$234.55
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 11.4%)
$413.09
(+76%)
Base:
(SPY PE: 16.3, Growth: 11.4%)
$324.54
(+38%)
Bear:
(PE: 13.8, Growth: 11.4%)
$275.85
(+17%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (29x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 29.15 | Current EPS (TTM): $8.04
Bull Case
$462.78
(+97%)
Analyst growth 79.5%, PE expands to 32.1
Base Case
$420.71
(+79%)
Market implied 79.5%, PE stable at 29.2
Bear Case
$159.39
(-32%)
Severe decline -20.0%, PE contracts to 24.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 02, 2026 6:12 PM ET
Data refreshes hourly during market hours. Next update: 7:12 PM
Data refreshes hourly during market hours. Next update: 7:12 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IQV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin Hern
SELL
2026-03-16
Ro Khanna
SELL
2026-02-24
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$630 | 53 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$188 | 61 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$283 | 59 HOLD |
Advanced IQV Option Strategies
Professional options setups generated by AI based on today's IQV price and gamma walls.
